Primary Antifungal Prophylaxis with Low-Dose Intravenous Amphotericin B in Hematological Malignancies. Results of a Pilot Study

Publisher： Karger

E-ISSN： 2296-5262|23|2|145-150

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.23, Iss.2, 2000-05, pp. : 145-150

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Primary antifungal prophylaxis with micafungin in patients with haematological malignancies: real‐life data from a retrospective single‐centre observational study

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 3, 2015-03 ,pp. : 258-264

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost-Benefit Assessment of Antifungal Prophylaxis with Liposomal Amphotericin B in Neutropenic Patients

By  

Oncology Research and Treatment, Vol. 30, Iss. 12, 2007-11 ,pp. : 621-626

Karger

Access to resources Recommend Favorite

The QTc Effect of Low‐Dose Methadone for Chronic Pain: A Prospective Pilot Study

By  

PAIN MEDICINE, Vol. 16, Iss. 6, 2015-06 ,pp. : 1112-1121

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk of Onset of Hematological Malignancies in Patients Infected with the Hepatitis B Virus: Results from a Large-Scale Retrospective Cohort Study in China

By  

Acta Haematologica, Vol. 137, Iss. 4, 2017-05 ,pp. : 209-213

Karger

Access to resources Recommend Favorite

Low‐dose short‐term hepatitis B immunoglobulin with high genetic barrier antivirals: the ideal post‐transplant hepatitis B virus prophylaxis?

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 17, Iss. 3, 2015-06 ,pp. : 329-333

John Wiley & Sons Inc

Access to resources Recommend Favorite